Post by
99942Apophis on Jul 26, 2021 2:50pm
Move to TSX
Should patients 16, 17 & 18 demonstrate a majority or even all show 100 percent CR then the assumption can be made that most of the remaining patients to be given the optimized treatment will also have that result. We have heard in the past at some point Theralase will move from the Venture Exchange to the senior board TSX and also go after a Nasdaq listing, I would guess once 50 or 60 patients have proven this to be highly effective in the destruction of Cancer will we see that move or will that happen upon completion of Phase 2. Any thoughts?
Comment by
skys1 on Jul 26, 2021 3:11pm
Please excuse me! That should have been June of 2016, not 1996. I guess I'm showing my age.
Comment by
livermore2 on Jul 26, 2021 3:15pm
I think this would happen if we approach a 1billion MC which can happen very quickly in the biotechnology industry. My fear is being taken out by a rival pharma company beforehand though.
Comment by
livermore2 on Jul 26, 2021 3:40pm
Yes, I agree with your thinking. Just look at Moderna's stock price over the last year and a half- know it's a special case but always good to dream!!!